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mproved Surgical
utcome for Chronic Severe
ortic Regurgitation With
everely Depressed Left
entricular Systolic Function*
aul A. Grayburn, MD, FACC
allas, Texas
hronic severe aortic regurgitation (AR) imposes a com-
ined pressure and volume overload on the left ventricle
LV). Fortunately, preload reserve and compensatory hyper-
rophy allow most patients with chronic severe AR to
aintain normal LV systolic function for many years. Most
uch patients are asymptomatic and have an excellent
rognosis (1–3). Over the course of time, adverse loading
onditions may cause LV systolic dysfunction, which often
recedes the onset of symptoms. The standard of care is to
onitor patients with chronic severe AR carefully and
perate at the first sign of symptoms or LV dysfunction
4–6). However, some patients do not come to medical
ttention until they already have severely depressed LV
ystolic function. The question then arises as to whether
uch patients will benefit from surgery because of relief of
fterload mismatch or whether it is too late to operate
ecause irreversible LV dysfunction has already occurred.
See page 1465
In this issue of the Journal, Bhudia et al. (7) report the
esults of surgery for pure, chronic severe AR in 724 patients
ho underwent surgery at the Cleveland Clinic from 1972
o 1999. Of these, 88 (12%) had severe LV dysfunction
efined as left ventricular ejection fraction (LVEF) 30%.
atients with severe LV dysfunction tended to be older (56
s. 50 years) and male (91% vs. 67%). Propensity-matching
as used to select 77 well-matched pairs of subjects with
nd without severe LV dysfunction. In this group, hospital
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From Baylor Heart and Vascular Institute, Baylor University, Dallas, Texas. Dr.
rayburn receives grant support from the National Institutes of Health, Bristol-w
yers Squibb, POINT Biomedical, Evalve, Medtronic, and Guidant; however, none
f these grants are related to aortic regurgitation or cardiac surgery.ortality before 1985 was 17% in those with severe LV
ysfunction compared with 3% without it (p  0.03). In
atients who underwent surgery after 1985, there were no
ospital deaths in either group. Long-term survival was
orse with severe LV dysfunction (81% vs. 92% at 1 year,
8% vs. 81% at 5 years, 46% vs. 62% at 10 years), but this
as mostly the result of hospital mortality in the patients
ndergoing surgery before 1985. In those patients who
nderwent surgery after 1985, there was no significant
ifference in long-term survival. Importantly, the mean LV
nd-diastolic and -systolic diameters were 7.5 0.7 cm and
.9  0.8 cm, respectively. Thus, the patients in this study
ad not only depressed LVEF but also increased LV
imensions, which would indicate a poor surgical outcome
ased on older studies.
What is the take-home message for clinicians? First, this
tudy suggests that, in the current era, operative mortality
or chronic severe AR is low, even for patients with a
ilated, severely dysfunctional LV. This result confirms a
rior study from the Mayo Clinic, in which operative
ortality was 3.7% for patients with severe AR and LVEF
35% (8). That the operative mortality for such patients
as declined over the course of time is probably multifac-
orial, reflecting improvements in surgical and anesthetic
echniques, cardioprotection, prosthetic valve design, post-
perative care, and concomitant medical therapy. Second,
his study indicates that long-term survival in the current era
s not significantly different between patients with and
ithout severely depressed LV systolic function. The reason
or this somewhat surprising finding is not clear from the
ata presented. It has been previously shown that surgery for
ymptomatic patients with severe AR reduces LV volumes,
V mass, and wall stress, and increases LVEF (9–12).
ccordingly, it is tempting to speculate that surgical relief of
he afterload mismatch, perhaps accompanied by appropri-
te medical therapy, resulted in favorable LV remodeling
nd improvement in LV systolic function. However, the
tudy does not report temporal changes in LV dimensions
r LVEF after surgery, nor does it report what medicines
ere prescribed.
A few caveats should be mentioned to keep the data in
roper perspective. First, because this was a retrospective,
bservational study, there was likely a selection bias that
avored patients thought to be good candidates for aortic
alve surgery. Second, these results come from a high-
olume center with skilled surgical, medical, and ancillary
ersonnel. Third, most of these patients were men. Small,
lderly women are more likely to have worse outcomes with
ardiovascular surgery and are predisposed to patient-
rosthesis mismatch (13). In individual patients, age, gen-
er, and aortic annulus size should be considered, along
ith other comorbidities that could limit the effectiveness of
ortic valve surgery. Finally, Carabello (14) has suggested
hat patients with chronic severe AR, poor LV function
ith marked dilation, and low systolic blood pressure may
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April 3, 2007:1472–3 Editorial Commente a particularly high-risk group, presumably because they
o not have sufficient afterload mismatch to expect LV
unctional recovery after surgery.
The American College of Cardiology/American Heart
ssociation 2006 Guidelines for the Management of Pa-
ients with Valvular Heart Disease state that “AVR is
ndicated for symptomatic patients with severe AR irrespec-
ive of LV systolic function” and that “AVR is indicated for
symptomatic patients with chronic severe AR and LV
ystolic dysfunction (EF 0.50 or less) at rest” (4). A lower
imit on LVEF is not mentioned in the guidelines. The
tudy by Bhudia et al. (7) supports this position by showing
o difference in hospital mortality or long-term survival in
atients with chronic severe AR and severely depressed LV
ystolic function. Although such patients should not be
enied surgery, they should be referred to high-volume
enters experienced in the management of high-risk, com-
lex valvular heart disease.
eprint requests and correspondence: Dr. Paul A. Grayburn,
aylor University Medical Center, Baylor Heart and Vascular
nstitute, 621 North Hall Street, Suite H030, Dallas, Texas 75226.
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